We are live on ! Find out more
XENT

Intersect ENT, Inc

Delisted

XENT was delisted on the 12th of May, 2022.

121 hedge funds and large institutions have $331M invested in Intersect ENT, Inc in 2020 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 47 increasing their positions, 32 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

442% more call options, than puts

Call options by funds: $2.48M | Put options by funds: $457K

47% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 32

21% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 19

1% more funds holding

Funds holding: 120121 (+1)

57% less capital invested

Capital invested by funds: $776M → $331M (-$445M)

75% less funds holding in top 10

Funds holding in top 10: 41 (-3)

Holders
121
Holders Change
+1
Holders Change %
+0.83%
% of All Funds
2.67%
Holding in Top 10
1
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-75%
% of All Funds
0.02%
New
23
Increased
47
Reduced
32
Closed
19
Calls
$2.48M
Puts
$457K
Net Calls
+$2.02M
Net Calls Change
-$17.3M
Name Holding Trade Value Shares
Change
Change in
Stake
Two Sigma Advisers
26
Two Sigma Advisers
New York
$2.99M +$3.83M +172,800 +217%
Two Sigma Investments
27
Two Sigma Investments
New York
$2.8M +$3.79M +170,805 +261%
GLA
28
Great Lakes Advisors
Illinois
$2.36M +$4.41M +198,886 New
Charles Schwab
29
Charles Schwab
California
$2.3M +$82.2K +3,709 +2%
Jacobs Levy Equity Management
30
Jacobs Levy Equity Management
New Jersey
$2.25M +$3.91M +176,362 +1,290%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$2.08M +$434K +19,569 +13%
D.E. Shaw & Co
32
D.E. Shaw & Co
New York
$2.04M -$6.38M -287,563 -62%
Barclays
33
Barclays
United Kingdom
$2M -$7.39M -333,119 -66%
PHP
34
Parkman Healthcare Partners
Connecticut
$1.97M +$896K +40,423 +32%
WRF
35
Waddell & Reed Financial
Kansas
$1.64M -$3.38M -152,263 -52%
Bank of America
36
Bank of America
North Carolina
$1.4M +$1.67M +75,472 +176%
State of New Jersey Common Pension Fund D
37
State of New Jersey Common Pension Fund D
New Jersey
$1.26M
AQR Capital Management
38
AQR Capital Management
Connecticut
$1.15M +$1.47M +66,363 +215%
KFO
39
Kopp Family Office
Minnesota
$1.04M +$280K +12,630 +17%
SG Americas Securities
40
SG Americas Securities
New York
$960K +$1.07M +48,048 +146%
MOACM
41
Mutual of America Capital Management
New York
$936K -$77.2K -3,480 -4%
Renaissance Technologies
42
Renaissance Technologies
New York
$866K +$1.2M +53,900 +281%
Wells Fargo
43
Wells Fargo
California
$842K +$357K +16,088 +29%
O
44
OrbiMed
New York
$812K +$1.52M +68,553 New
AP
45
Americana Partners
Texas
$776K
Canada Pension Plan Investment Board
46
Canada Pension Plan Investment Board
Ontario, Canada
$769K +$1.44M +64,900 New
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$742K +$4.43K +200 +0.3%
Swiss National Bank
48
Swiss National Bank
Switzerland
$724K +$17.7K +800 +1%
QI
49
QS Investors
New York
$695K -$28.9K -1,302 -2%
State of Wisconsin Investment Board
50
State of Wisconsin Investment Board
Wisconsin
$665K +$222K +10,000 +22%

XENT Hedge Fund Activity: Q1 2020 in Review

121 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q1 2020, worth a combined $331M — down 57% from $776M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new XENT positions and 19 closed out — a net gain of 4 holders — while 47 added to existing stakes and 32 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $35.1M. The largest seller was HealthCor Management, exiting entirely with an estimated $63.2M sold.

  • 121 institutional investors held Intersect ENT, Inc (XENT) as of Q1 2020, up from 120 in Q4 2019.
  • Funds reported $331M of Intersect ENT, Inc stock for Q1 2020, down 57% quarter-over-quarter.
  • 23 funds opened new Intersect ENT, Inc positions in Q1 2020 and 19 closed out, a net change of +4 holders.
  • The largest Intersect ENT, Inc buyer in Q1 2020 was Fidelity Investments, an estimated $35.1M added.
  • The largest Intersect ENT, Inc seller in Q1 2020 was HealthCor Management, an estimated $63.2M sold.

Based on aggregated 13F filings for Q1 2020.